Revenue Analysis

ABBV

AbbVie Inc.

$228.74
+0.76%

Price vs Sales Yield

Current Valuation

Sales Yield
13.99%
P/S
7.1x
P/E Ratio
96.2x
PEG Ratio
0.54

P/S Averages

Median (Fair Value)
5.8x
Industry (Damodaran)
5.6x
1-Year Avg
7.1x
3-Year Avg
7.2x
5-Year Avg
7.2x
Min / Max
4.0x / 7.7x

Revenue Growth

YoY Growth
3.7%
3-Year CAGR
0.1%
5-Year CAGR
11.1%

Financial Snapshot

Market Cap
$401.39B
Enterprise Value
$463.63B
Revenue (TTM)
$61.16B
Dividend Yield
2.92%

Valuation Context

vs 5-Year Average

-1%

Near average

Sales Yield

13.99%

High yield

vs Industry (Drugs (Pharmaceutica...)

26%

Above industry avg

Data Points

751

daily data points